CYIOS Corporation (CYIO) Fair Value & Analysis
Healthcare · US · Market cap $473K
CYIOS Corporation
CYIO · US
Fair value as of: Jun 26, 2026
From 13 valuation models · updated 7 days ago
Fair value updated Jun 26, 2026 — revised from $0.0300 to $0.0016 (−94.7%) since Jun 24, 2026. Share price −5.6% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0010 – $0.0056 · fair‑value band $0.0016 – $0.0016 · the $0.0016 price screens below the $0.0016 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
CYIOS Corporation (CYIO) currently trades at $0.0016, while our model-based Fair Value estimate is $0.0016 — implying the stock looks roughly 0.1% undervalued today. We read business quality at 40/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, CYIOS Corporation generated revenue of $1.5M at a net margin of -4.1%. Revenue declined 49.7% year over year. It earns a return on equity of -17.9%. Net debt stands at $2.1M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CYIOS Corporation reported revenue of $11.9M in FY2025 versus $744K in FY2021, a compound +100.0%/yr. Reported net income was $497K in FY2025.
Is CYIO fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FSNUY | $11.27 | $8.25 | -27% |
| Q0F Q0F | 2.76 SGD | 1.28 SGD | -54% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.26 | -26% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.76 | R$30.33 | -7% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is CYIOS Corporation (CYIO) undervalued?
What is the fair value of CYIO?
What is the quality score of CYIO?
What is the revenue of CYIOS Corporation (CYIO)?
What is the net profit margin of CYIO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.